PharmaShots | Incisive News in 3 Shots

Subscribe Now

Opsidio

Opsidio Reports 1st Patient Dosing in P-IIa (Opscf-201) Study for the Treatment Of Atopic Dermatitis

Opsidio Reports 1st Patient Dosing in P-IIa (Opscf-201) Study for the Treatment Of Atopic Dermatitis

November 30, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us